JSC Ukrgazvydobuvannia in January-March 2019 increased its net profit by 3% (UAH 222.065 million) compared to the same period last year, to UAH 7.546 billion.
According to the report on the company’s website, its net income for the first quarter increased by 21% (UAH 3.924 billion), to UAH 22.609 billion, gross profit by 5.7% (UAH 543.67 million), to UAH 10.150 billion.
As reported, Ukrgazvydobuvannia in 2018 reduced its net profit by 11% compared to 2017, to UAH 27.135 billion (about $1 billion). Its net income for 2018 increased by 5.2%, to UAH 78.970 billion, while gross profit decreased by 8.8%, to UAH 38.368 billion.
Pharmacy sales in Ukraine in April 2019 in monetary terms rose by 16.1% compared with April 2018, to UAH 8.073 billion, but decreased by 3.7% in natural terms, to 139.8 million packages.
According to the Apteka edition, with reference to data from the analytical system PharmXplorer/Pharmstandard, in April 2019 sales of medicines in monetary terms grew by 14.6% compared to April 2018, to UAH 6.703 billion, in natural terms by 4%, to 88.9 million packs.
The Ukrainian pharmaceutical companies Farmak, the corporations Arterium and Darnitsa, as well as Teva (Israel) and Sanofi (France) are among the top five marketing organizations.
As reported, in 2018 pharmacy sales in Ukraine in monetary terms increased by 23.4% compared with 2017, to UAH 84.574 billion, sales in natural terms for the period decreased by 0.84% compared with 2017, to 1.52 billion packages.
Astarta in the first quarter of 2019 received a net loss of EUR4.43 million compared to a net profit of EUR3.7 million in the first quarter of last year, linking the deterioration of financial indicators with unfavorable sugar market conditions and higher financial expenses.
According to a company report on the Warsaw Stock Exchange, its revenue, due to good results of soybeans processing and crop production, rose by 27.8% compared to January-March 2018, to EUR115.79 million, and EBITDA by 2%, to EUR13.61 million.
Astarta’s net debt declined slightly in the first quarter, from EUR295.45 million to EUR292.99 million, which, however, was significantly more than a year before, EUR201.5 million.
Mainly due to low prices for sugar and other commodities, Astarta broke a number of financial covenants on bank loans at the end of the first quarter, and therefore reclassified loans worth EUR121 million as current ones, but the management expects that lenders will not require early repayment.
According to the report, the investment program of the company for 2019 will be limited by capital expenditures for maintenance, completion of the program of elevators infrastructure and the acquisition of grain wagons.
